Combined but not single treatment with ethinylestradiol/levonorgestrel and spironolactone reduces plasminogen activator inhibitor-1 in insulin-resistant ovariectomised rats

OBJECTIVE: Increased circulating level of plasminogen activator inhibitor-1 (PAI-1) is associated with menopausal oestrogen deficiency. We therefore hypothesised that the combined oral contraceptive (COC) with spironolactone (SPL) improves insulin resistance (IR) in ovariectomised (OVX) rats by redu...

Descripción completa

Detalles Bibliográficos
Autores principales: Aremu, Adeyanju Oluwaseun, Lilian, Dibia Chinaza, Olufemi, Soladoye Ayodele, Aderemi, Olatunji Lawrence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6927203/
https://www.ncbi.nlm.nih.gov/pubmed/31856649
http://dx.doi.org/10.1177/1470320319895933

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6927203/
https://www.ncbi.nlm.nih.gov/pubmed/31856649
http://dx.doi.org/10.1177/1470320319895933

Ejemplares similares